Results 291 to 300 of about 224,992 (367)
The use of rituximab as a pre‐emptive treatment in immune‐mediated thrombotic thrombocytopenic purpura (iTTP) is the current standard of care. However, for patients refractory to rituximab or for those with contraindication, further treatment guidelines are scarce.
Julia Weisinger+4 more
wiley +1 more source
Exploring the shared molecular mechanisms of primary hypertension and IgA vasculitis through a case report and combining bioinformatics analysis. [PDF]
Wei Q+6 more
europepmc +1 more source
Cutaneous Side Effects of PD‐1 Inhibitors: A Single‐Center Retrospective Study
ABSTRACT Background The introduction of immune checkpoint inhibitors (ICIs) opened a new era in cancer immunotherapy. In particular, PD‐1 inhibitors have shown remarkable efficacy in various cancers, most notably melanoma. However, the widespread use of immune checkpoint inhibitors comes with the challenge of immune‐related adverse events (irAEs), with
Melánia Pozsgai+5 more
wiley +1 more source
Long-term efficacy and safety of the Lupus-Cruces Nephritis protocol: a propensity score study of the Lupus-Cruces and Lupus-Bordeaux cohorts. [PDF]
Ruiz-Irastorza G+5 more
europepmc +1 more source
The ‘nephrotoxins’ were stopped: what is in a name and its impact on kidney and cardiac health?
Abstract The term ‘nephrotoxin’ is often imprecisely applied to medications that are not inherently toxic to the kidneys, including renin‐angiotensin‐aldosterone system inhibitors, sodium‐glucose co‐transporter 2 inhibitors, diuretics and metformin. These drugs are frequently included in ‘sick day rules’ and may be prematurely discontinued during acute
Catherine Mao, Bobby Chacko
wiley +1 more source
Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Single-Center Experience of Biopsy-Proven Cases. [PDF]
Kommer A+3 more
europepmc +1 more source
ABSTRACT Candida infections represent a major component of invasive and non‐invasive mycoses globally, including the countries in the Arabian Peninsula. In this review, we present epidemiological features and trends, clinical manifestations, species distribution, antifungal susceptibility, and outcomes available for candidemia and candiduria in six ...
Suhail Ahmad+14 more
wiley +1 more source